Dr. Wang has long been engaged in clinical practice, research and the teachings of respiratory problems such as pulmonary embolism, pulmonary hypertension, respiratory failure, pulmonary heart disease, chronic obstructive pulmonary diseases (COPD, Chronic Bronchitis Emphysema), new respiratory infectious diseases and tobacco epidemiology. He has achieved many important innovations including thrombolysis therapy and sequential mechanical ventilation, which have been added to the international treatment guidelines. He is in charge of multiple national research projects and international programs.
Dr. Wang has published more than 100 articles in international authoritative medical journals, such as the New England Journal of Medicine, The Lancet and Annals of Internal Medicine (Ann Intern Med). He has been honored as the First Place winner (once) and Second Place winner (three times) of the National Science and Technology Progress Award, and has received the Outstanding Contribution Award for Tobacco Control of WHO and the Scientific and Technological Progress Award of the Ho Leung Ho Lee Foundation.
Dr. Wang has made impressive progress in disciplinary construction and hospital management when he served as senior administrator of medical institutions including the Beijing Chao-Yang Hospital, Beijing Hospital and the China-Japan Friendship Hospital. He once worked as the Deputy Director-General of the Department of Health Sciences, Technology and Education of China‘s National Health and Family Planning Commission (NHFPC), presiding over the department by promoting medical education and research at the national level.